Search for: "Purdue Pharma Manufacturing L.P."
Results 21 - 40
of 42
Sorted by Relevance
|
Sort by Date
5 May 2009, 5:00 am
Purdue Pharma, L.P., 292 F. [read post]
17 Sep 2009, 4:30 am
Once adequate warning is given, no more is legally required of the manufacturer. [read post]
15 Sep 2011, 5:00 am
Nor is a manufacturer responsible for how a learned intermediary conducts his business. [read post]
28 Sep 2016, 8:39 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
13 Oct 2016, 6:50 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
16 Jan 2017, 5:44 pm
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
14 Nov 2016, 9:16 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
8 Feb 2017, 3:09 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
24 Jun 2010, 5:00 am
Proctor & Gamble Manufacturing Co., 1998 WL 686767 (N.D. [read post]
9 Apr 2015, 5:00 am
App. 1994), a non-medical learned intermediary decision mentioned in Watts, since Davis held that “[the learned intermediary], a leading manufacturer of aircraft, understood the possible consequences” of the hazard at issue. [read post]
24 Feb 2011, 1:49 pm
In addition to protecting the physician patient relationship, the purpose of the learned intermediary rule in ensuring that decisions were made by the person most knowledgeable of both the patient’s condition and the risks and benefits of the proposed therapy also came into play: The relationship between the physician-patient-manufacturer applies equally to the relationship between the physician-patient and pharmacist. [read post]
23 Sep 2011, 12:08 pm
Purdue Pharma L.P., 292 F.Supp.2d 1346, 1354 (S.D. [read post]
1 Jan 2024, 9:05 pm
Purdue Pharma L.P. [read post]
28 Jun 2007, 10:16 am
Purdue Pharma Co., 297 F. [read post]
11 Jun 2010, 2:15 pm
After Romag challenged the authen-ticity of the manufacturer's invoice, Mr. [read post]
2 Jun 2011, 12:46 pm
Purdue Pharma, L.P., 295 F. [read post]
5 Feb 2009, 12:19 pm
Purdue Pharma Co., 297 F. [read post]
5 Jul 2007, 10:37 am
Purdue Pharma, L.P., 821 N.E.2d 141, 146 (Ohio 2004); Vaccariello v. [read post]
25 May 2011, 11:46 pm
United States, 429 U.S. 17 (1976), and Precision Instruments Manufacturing Co. v. [read post]
19 Sep 2013, 9:53 am
., 712 F.3d 51 (1st Cir. 2013), and Harden Manufacturing Corp. v. [read post]
